Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM P/E Multiple | 17.4x - 19.3x | 18.4x |
| Selected Fwd P/E Multiple | 20.5x - 22.6x | 21.6x |
| Fair Value | $126.21 - $139.50 | $132.85 |
| Upside | -1.6% - 8.8% | 3.6% |
| Benchmarks | - | Full Ticker |
| CONMED Corporation | - | NYSE:CNMD |
| Becton, Dickinson and Company | - | NYSE:BDX |
| LeMaitre Vascular, Inc. | - | NasdaqGM:LMAT |
| Haemonetics Corporation | - | NYSE:HAE |
| OraSure Technologies, Inc. | - | NasdaqGS:OSUR |
| Abbott Laboratories | - | BVL:ABT |
| - | - | - |
| Select Price / LTM EPS Ratio | ||||||||
| Benchmark Companies | ||||||||
| CNMD | BDX | LMAT | HAE | OSUR | ABT | |||
| NYSE:CNMD | NYSE:BDX | NasdaqGM:LMAT | NYSE:HAE | NasdaqGS:OSUR | BVL:ABT | |||
| Historical Net Income Growth | ||||||||
| 5Y CAGR | 35.8% | 9.5% | 19.7% | 16.4% | NM- | 29.5% | ||
| 3Y CAGR | 28.4% | 4.0% | 17.8% | 13.9% | NM- | 23.8% | ||
| Latest Twelve Months | 105.4% | 36.5% | 46.3% | 2.8% | -136.3% | 139.9% | ||
| Historical Net Income Profit Margin | ||||||||
| 5 Year Average Margin | 2.4% | 8.3% | 16.1% | 8.4% | -1.7% | 16.4% | ||
| Prior Fiscal Year | 5.2% | 7.6% | 15.6% | 9.9% | 13.2% | 14.2% | ||
| Latest Fiscal Year | 10.1% | 8.4% | 20.0% | 9.0% | -10.5% | 31.8% | ||
| Latest Twelve Months | 10.1% | 8.4% | 20.0% | 9.5% | -10.5% | 31.8% | ||
| Current Trading Multiples | ||||||||
| EV / LTM EBITDA | 10.9x | 14.0x | 30.9x | 11.7x | 1.5x | 21.4x | ||
| Price / LTM Sales | 1.2x | 2.9x | 9.2x | 2.2x | 1.3x | 5.4x | ||
| LTM P/E Ratio | 11.9x | 34.3x | 46.0x | 23.7x | -12.2x | 17.0x | ||
| Low | Mid | High | ||||||
| Benchmark LTM P/E Ratio | -12.2x | 23.7x | 46.0x | |||||
| Historical LTM P/E Ratio | 24.4x | 34.2x | 56.1x | |||||
| Selected P/E Multiple | 17.4x | 18.4x | 19.3x | |||||
| (x) LTM Net Income | 13,451 | 13,451 | 13,451 | |||||
| (=) Equity Value | 234,603 | 246,950 | 259,298 | |||||
| (/) Shares Outstanding | 1,734.3 | 1,734.3 | 1,734.3 | |||||
| Implied Value Range | 135.27 | 142.39 | 149.51 | |||||
| FX Rate: USD/USD | 1.0 | 1.0 | 1.0 | Market Price | ||||
| Implied Value Range (Trading Cur) | 135.27 | 142.39 | 149.51 | 128.20 | ||||
| Upside / (Downside) | 5.5% | 11.1% | 16.6% | |||||
| Equity Value | |||||||
| Benchmark Companies | |||||||
| (in millions) | CNMD | BDX | LMAT | HAE | OSUR | ABT | |
| Value of Common Equity | 1,485 | 57,393 | 1,943 | 2,972 | 229 | 222,340 | |
| (/) Shares Outstanding | 30.9 | 287.1 | 22.6 | 50.2 | 77.5 | 1,734.3 | |
| Implied Stock Price | 48.02 | 199.88 | 86.15 | 59.15 | 2.96 | 128.20 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 48.02 | 199.88 | 86.15 | 59.15 | 2.96 | 128.20 | |
| Trading Currency | USD | USD | USD | USD | USD | USD | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |